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Abstract
Poor reproductive performance remains a major issue in the dairy industry, with low concep-
tion rates having a significant impact on milk production through extended calving intervals.
A major limiting factor is the lack of reliable methods for early pregnancy diagnosis. Identifi-
cation of animals within a herd that fail to conceive within 3 weeks after insemination would
allow early re-insemination and shorten calving intervals. In a previous study, we found an
increase in plasma miR-26a levels in Day 16-pregnant relative to non-pregnant heifers, how-
ever changes in miRNA levels that early during pregnancy were very small which likely pre-
vented the identification of robust biomarkers. In this study, we extended our analyses to a
wider interval during pregnancy (Days 8 to 60, n = 11 heifers) with the rationale that this may
facilitate the identification of additional early pregnancy miRNA biomarkers. Using small
RNA sequencing we identified a total of 77 miRNAs that were differentially expressed on
Day 60 relative to Day 0 of pregnancy. We selected 14 miRNAs for validation by RT-qPCR
and confirmed significant differences in the expression of let-7f, let-7c, miR-30c, miR-101,
miR-26a, miR-205 and miR-143 between Days 0 and 60. RT-qPCR profiling throughout
Days 0, 8, 16 and 60 of pregnancy showed a distinct increase in circulating levels of miR-
26a (3.1-fold, P = 0.046) as early as Day 8 of pregnancy. In summary, in contrast to earlier
stages of pregnancy ( Day 24), marked differences in the levels of multiple miRNAs can
be detected in circulation by Day 60 in cattle. Retrospective analyses showed miR-26a lev-
els to be increased in circulation as early as Day 8, sooner than previously reported in any
species, suggesting a biological role for this miRNA in the very early events of pregnancy.
Introduction
Based on government estimates for 2015 [1] the UK dairy herd comprises 1.8 million cattle
which produce 14.3 billion litres of milk annually (7,944 litres per animal per annum). This
generates approximately £3.7 billion per annum, which is of significant importance for the UK
economy overall. However, for the past 50 years the dairy industry has suffered from reduced
profitability, despite a continuous net increase in milk production (which has been estimated
at 1% per cow annually) [2]. In negative correlation with milk production, fertility decreased
during the same period, partially as a consequence of the introduction of North American
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Holstein-Friesian genes in European cattle populations [2, 3]. Calving rates as low as 34% have
been reported in high-producing dairy cows, with pregnancies being lost mainly during the
first trimester [4]. A number of risk factors for poor reproductive performance have been iden-
tified, including immune, metabolic and endocrine parameters, with post-partum energy bal-
ance being of major importance [5]. Recently, the inclusion of reproductive traits in genetic
selection programs has begun in some countries, aiming to stop the decline in reproductive
performance in dairy herds, however many issues still need to be addressed [4, 6].
Key to the issue of low fertility is the inability to reliably detect early pregnancy in dairy
cows, which prevents prompt re-insemination of animals failing to conceive at first service, in
turn leading to extended calving intervals and suboptimal milk production [7, 8]. Current
pregnancy detection methods, including trans-rectal ultrasound and palpation as well as bio-
chemical methods such as progesterone measurements in milk, are only accurate after the first
3 weeks of pregnancy, missing out the critical window of opportunity for re-insemination of
cows after failed conception, thus being inadequate to efficiently support modern intensive
management systems [9].
MicroRNAs (miRNAs) are small non-coding RNAs that act as post-transcriptional gene
regulators (reviewed in [10]). The intrinsically high stability of miRNAs in bio-fluids together
with, in some cases [11], their tissue-specificity, confers miRNAs a significant potential as
non-invasive biomarkers of disease [12–14]. So far, a plethora of studies have shown the asso-
ciation between specific plasma and serum miRNA signatures and human cancer, heart dis-
ease and autoimmune diseases (reviewed in [15, 16]), as well as, in a reproductive context,
pregnancy progression and preeclampsia [17–19].
Despite extensive evidence in humans, the potential utility of circulating miRNAs as tissue
biomarkers in livestock has not been explored widely, with a handful of recent studies identify-
ing potential biomarkers of metabolic status and infection in chicken, pig and cow [20–22].
We recently reported for the first time changes in circulating miRNA levels during early preg-
nancy (Days 16 and 24) in cattle [23]. Perhaps not surprisingly, differences in miRNA levels at
such early stage of pregnancy were in general very small, which, considering intrinsic biases
associated with RNA sequencing [24], may have prevented the wide identification of robust
miRNA biomarkers. Of note, previous studies in humans have shown that circulating miRNA
profiles associated with pregnancy become more pronounced as pregnancy progresses [19].
Based on this, we followed up on our previous study by focusing on a later stage of pregnancy
(Day 60) with the hypothesis that differences in levels of plasma miRNAs between Day 60-preg-
nant and non-pregnant (Day 0) heifers would be larger than the differences identified previ-
ously during Days 16 and 24 of pregnancy, and that this may facilitate the retrospective
identification of early pregnancy biomarkers.
Methods
Experimental animals and sample collection
Eleven Holstein-Friesian heifers, 14–17 months old, that had never been inseminated, were
oestrus-synchronised and artificially inseminated at oestrus following previously described
procedures [23]. Pregnancy was confirmed by trans-rectal ultrasound on Days 35 and 60 post-
insemination. Plasma samples were collected from the jugular vein in EDTA tubes (Becton
Dickinson, USA) on Days 0, 8, 16 and 60 after insemination, as described before [23, 25]. The
ratio between miR-451 and miR-23a was used as an indicator of haemolysis [26]; most samples
had a miR ratio < 5, indicating absence of haemolysis (S1 Fig). All animal procedures were
carried out under the UK Home Office Animals (Scientific Procedures) Act 1986, license 60/
4604, with approval by the Ethical Review Committee, University of Edinburgh.
miRNAs and early pregnancy
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and materials.
Abbreviations: miRNA, microRNA; nt, nucleotide;
PCA, principal component analysis; qPCR,
quantitative polymerase chain reaction; RPMM,
reads per million mapped; RT, reverse
transcription.
Cells were obtained from whole blood samples (100 μL) that were centrifuged at 1,900 g for
10 min at 4˚C. The resulting supernatant was discarded and the cell pellet was re-suspended to
a volume of 250 μL. The fresh blood cell solution was then used for RNA extraction as
described below.
Additional body tissue samples were collected from 3–4 animals at a local abattoir and were
placed in ice-cold PBS until arrival at the laboratory. Tissues were then dissected, labelled,
weighed and snap-frozen using dry ice. All samples were stored at -80˚C until further use.
RNA extraction
RNA was extracted from 700 μL of plasma using TRIzol LS (Life Technologies, USA) following
the manufacturer’s protocol. Following homogenisation with TRIzol LS, 3.5 μL of exogenous
cel-miR-39-3p (5.6 x 108 copies per sample; Qiagen, Germany) were spiked into the homoge-
nate. Prior to RNA precipitation, 40 μg of glycogen (Sigma-Aldrich, USA) were added to each
sample to facilitate precipitation of RNA in the presence of 0.1 volume of 5 M ammonium ace-
tate salt (Sigma-Aldrich) as recommended by the manufacturer. RNA pellets were re-sus-
pended in 20 μL of RNase-free water (Qiagen) and used immediately in downstream protocols
or frozen at -80˚C until further use.
Blood cell suspensions (250 μL) were homogenised using 3 volumes of TRIzol LS and
extracted as per manufacturer instructions. RNA pellets were re-suspended in 10 μL of RNase-
free water and frozen at -80˚C until further use.
Other tissues (50 mg) were thawed in 1 mL of TRIzol LS and disrupted with Lysing Matrix
D (MP Biomedicals, UK) and a FastPrep FP120 Tissue Disruptor (Thermo Electron, USA)
using 2 consequent 30-second runs at a speed setting of 5. Following homogenisation, samples
were centrifuged at 10,000 g for 5 min at 4˚C and the resulting supernatant was aspirated. The
remaining steps for RNA extraction were carried out as described in the manufacturer’s proto-
col and the resulting RNA pellets were re-suspended in 40 μL of RNase free water. RNA con-
tent and quality in blood-cell and tissue samples were monitored using the Nanodrop ND-
1000 Spectrophotmeter (average RNA yield = 630 ng and A260/280 = 1.9, Thermo Fischer Scien-
tific, USA) and RNU6-2 expression levels.
Small RNA sequencing
Small RNA sequencing libraries were prepared from plasma samples using the TruSeq Small
RNA Library Preparation Kit (Illumina, USA) and submitted to 36-base single-end sequencing
on the HiSeq 2000 Sequencing System (Illumina). Raw sequencing data (publicly available on
the GEO database accession GSE83509, [27]) were analysed using the sRNAbench 1.0 tool [28,
29]. Briefly, the software was run in genome mode using default settings, with the bovine
genome (bosTau4) and miRBase 21 (accessed on 30 April 2015) [30, 31] as reference in order
to identify bovine miRNAs (bta-miR) and human miRNA homologues (hsa-miR). A single
nucleotide mismatch was allowed when mapping raw reads to known miRNA sequences and
reads without sequencing adaptor, with undetermined bases and reads below 15 nucleotides
(nt) in length being automatically removed from the analysis. For additional details about the
integrated analysis steps in sRNAbench please refer to the software manual.
Normalised reads (reads per million mapped, RPMM) obtained from sRNAbench were fil-
tered before being passed to edgeR 3.10.2 for differential expression analysis in R language
3.2.1 [32, 33]. Prior to analysis, miRNAs which were detected with less than 25 RPMM in
more than 8 samples per experimental group were excluded to reduce technical noise. Differ-
ential expression analysis was performed using edgeR’s paired mode on 197 miRNAs (S1 File)
miRNAs and early pregnancy
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using GLMfit. The statistical significance threshold was set to false discovery rate (FDR) =
0.05.
RT-qPCR
For plasma samples, cDNA was generated using the miScript II RT Kit (Qiagen) with 2 μL
of RNA extract used in each 10 μL reaction. For blood cell and tissue samples, 500 ng of
RNA were used in each 10 μL reaction. A Whatman-Biometra Thermocycler (Biometra,
USA) was used for the reverse transcription reaction using the conditions recommended by
the manufacturer.
The cDNA template was diluted 40-fold and added to 10 μL qPCR reactions that were pre-
pared in 96-well format using the miScript SYBR Green PCR Kit (Qiagen). Template amplifi-
cation was carried out using commercial species-specific miRNA primers (Qiagen) in an
Agilent MX3000P qPCR system (Agilent Technologies, USA), following the cycling conditions
suggested by the manufacturer. No-reverse transcriptase and no-template controls were used
for each plate. Raw fluorescence data were collected using MxPro software (Agilent Technolo-
gies). The amplification efficiency of different primers ranged between 81% and 115%, with R2
> 0.91. Expression levels were determined using freshly-made standard curves and data were
analysed further using Microsoft Excel (Microsoft Corporation, USA). For plasma samples,
expression levels were normalised to the mean expression of cel-miR-39-3p and miR-128
(miR-128 was the miRNA with the least variation across samples with coefficient of variation
(CV) = 15%). For blood cells and tissues, expression data were normalised to RNU6-2. Samples
with distinctly low RNU6-2 levels were excluded.
Statistical analyses were carried out using GraphPad Prism 7 (GraphPad Software, USA).
Differences in miRNA expression between Day 0 and Day 60 were assessed using paired t-
tests. For data involving more than 2 time points one-way rmANOVA was used to determine
the effect of Day, followed by Dunnett’s test to compare each time point with the Day 0 con-
trol. In all cases, normality was tested using the Shapiro-Wilk normality test, outliers were
identified with the ROUT test and then removed, and data were log2(x+1) transformed to
meet the tests’ normality criteria. Statistical significance thresholds for all tests were set to
P = 0.05.
Genomic cluster and pathway analyses
Information on genomic miRNA clusters in cow was obtained from miRBase 21 (accessed 23/
06/2016) [31]. Genomic clusters were numbered in order of decreasing size as shown on miR-
Base, and the overlap with our sequencing gene list was identified manually.
Target and pathway analysis was carried out using DIANA miRPath 3.0 [34]. Experimen-
tally validated miRNA targets were identified using DIANA-TarBase 7.0 and the Pathway
Union option (an a posteriori method) was used for pathway analysis. The integrated Fischer’s
exact test followed by FDR adjustment were used for statistical analysis. Enriched pathways
from the KEGG database were exported from the tool along with the corresponding FDR-cor-
rected P values. A significance threshold of FDR = 0.05 was applied to the corrected P values.
Results and discussion
Small RNA sequencing of bovine plasma
We sequenced a total of 22 plasma samples from Days 0 and 60 of pregnancy. On average, we
generated 16.1 million raw reads per sample (Table 1). There was a distinct peak in read
lengths between 20–23 nt, which matches the length of most mature miRNAs (Fig 1A). Out of
miRNAs and early pregnancy
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the total raw reads, 5.6 million (34.7%) corresponded to bovine and human mature miRNA
sequences (Table 1, Fig 1B). Across all samples, we identified up to 389 unique miRNAs pres-
ent at more than 10 reads. The 15 most abundant miRNAs in bovine plasma are listed in
Table 2. Eleven of these miRNAs were also among the most abundant in our previous cattle
study [23].
From our comprehensive miRNA profiling dataset we sought to identify stable miRNAs
which could be utilised for data normalisation in subsequent steps. The miRNA with the low-
est variability across samples was miR-128 (CV = 15%) followed by miR-151-3p and miR-425-
5p (Table 3). This result was confirmed by NormFinder, which listed miR-128 as the second
least variable miRNA in the dataset after miR-181b, with stability values of 0.07 and 0.06,
respectively (S1 File, Table 3). We choose miR-128 as an endogenous normaliser for subse-
quent RT-qPCR assays over miR-181b on the basis of its higher abundance (see ‘Methods‘).
Identification of differentially expressed miRNAs on Day 60 of pregnancy
Principal component analysis (PCA) revealed partial separation of samples based on Day of
pregnancy as shown in Fig 1C. Differential expression analysis identified 77 miRNAs which
were differentially expressed on Day 60 compared to Day 0 with FDR< 0.05 (Fig 1D, Table 4;
S1 File). Fourteen miRNAs changed by more than 2-fold between groups and the largest dif-
ference was observed for let-7c, which increased 4.5-fold on Day 60 of pregnancy.
Given the identification of miRNA clusters associated with pregnancy in other species [35],
we next sought to determine whether the miRNAs differentially expressed between Days 0 and
60 of pregnancy belonged to specific genomic clusters. A total of 82 miRNA clusters, each con-
taining 2 to 47 miRNAs, are registered for cow in miRBase 21. Using this as reference, we
found that 31 out of the 77 differentially expressed miRNAs belonged to a cluster, being pres-
ent together with at least another miRNA from the same cluster (Table 5). In total, 13 miRNA
clusters were represented among differentially expressed miRNAs. Among these were the
miR-379~656 cluster (known as C14MC in humans), represented by 5 miRNAs, and the miR-
17~92 and miR-106b~25 clusters, represented by 5 and 2 miRNAs, respectively (Table 5). The
C14MC cluster is known to be expressed in the placenta and is involved in foetal development;
circulating levels of C14MC miRNAs increase during human pregnancy [36, 19, 37, 38]. The
miR-17~92 and miR-106b~25 clusters are paralogues, with a demonstrated role in vascular
endothelial growth factor (VEGF)-mediated angiogenesis through targeting of phosphatase
and tensin homolog (PTEN), and a possible role in placental immune tolerance during the
first trimester of pregnancy; both clusters are highly expressed in the human placenta [36, 39–
41]. Finally, several members of the let-7 family known to be expressed in the human placenta
Table 1. Mean numbers of reads from sequencing of plasma samples on Days 0 and 60 of pregnancy (n = 11 heifers), including reads which were
excluded from further analyses.
Day 0 Day 60 Mean
Raw reads 15,382,609 16,807,294 16,094,951
Reads without adapter (excluded) 120,529 143,187 131,858
Short reads < 15 nt (excluded) 8,185,927 6,897,753 7,541,840
Low quality reads (excluded) 23,372 26,179 24,775
Reads mapping to bovine genome 7,052,780 9,740,175 8,396,478
Bovine miRNA reads 4,322,232 6,814,346 5,568,289
Bovine miRNAs detected at > 10 reads (range) 268–337 193–353 N/A
Human homologous miRNA reads 7,469 5,451 6,460
Human miRNAs detected at > 10 reads (range) 18–32 5–36 N/A
https://doi.org/10.1371/journal.pone.0174892.t001
miRNAs and early pregnancy
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[36] were present across multiple genomic clusters (Table 5). Overall, these results suggest
functionally conserved roles of a subset of pregnancy-associated miRNA clusters across
species.
To gain insight on the roles of the differentially expressed miRNAs during pregnancy we
carried out pathway enrichment analysis, using the DIANA web-tool [34], separately using
experimentally validated targets of all the up-regulated and down-regulated miRNAs on Day
60 of pregnancy (39,555 and 17,439 targets, respectively). There was significant overlap
Fig 1. Small RNA sequencing results. (A) Read length (mean ± SEM) distribution plot for all samples constructed using raw reads. (B) Barplot showing
total, mapped and miRNA reads for each plasma sample. Sample P60_17 generated very few miRNA reads, however it was included because it clustered
normally in subsequent principal component analysis (PCA). (C) PCA plot using transformed normalised data and showing partial separation between Day 0
and Day 60 samples. (D) Volcano plot showing differences in individual miRNA values between Days 0 and 60 of pregnancy, using transformed normalised
data. Values with fold-change > 2 and FDR < 0.05 are highlighted in red.
https://doi.org/10.1371/journal.pone.0174892.g001
miRNAs and early pregnancy
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between enriched pathways targeted by up-regulated and down-regulated miRNAs (S2 File),
and these common pathways included fatty acid synthesis and metabolism, extracellular cell
membrane (ECM)-receptor interaction, adherens junction, Hippo signalling and the thyroid
hormone, p53 and cell cycle pathways. Up-regulated miRNAs in pregnancy also targeted the
forkhead O (FOXO) and transforming growth factor beta (TGF-β) signalling pathways. These
results suggest roles of miRNAs in regulating cell metabolism as well as proliferation/survival/
migration processes involved in tissue growth during pregnancy.
Validation of sequencing data using RT-qPCR
Previous studies with human tissues have shown only partial agreement in miRNA expression
data generated using different profiling platforms [42]. Thus, we set out to validate our results
from sequencing using RT-qPCR. Fourteen differentially expressed miRNAs were selected for
validation (Table 6) based on both their relative abundance (RPMM) and fold-change between
Days 0 and 60 (Table 4, S1 File). For 11 out of the 14 miRNAs, RT-qPCR results agreed with
those from sequencing (Table 6, Fig 2A), although statistical significance was obtained only for
7 miRNAs, namely let-7c, -7f, miR-101, -30c, -26a, -143 and -205. Six miRNAs were expressed
at significantly higher levels (up to 6-fold, P< 0.05) on Day 60 compared to Day 0, while miR-
205 was significantly lower on Day 60 (1.5-fold, P< 0.05, Fig 2B, Table 6). Our subsequent
analyses focused on these 7 miRNAs.
Potential roles for these miRNAs during pregnancy can be speculated based on previous lit-
erature and the results of gene ontology analyses above (S2 File). Four of the seven miRNAs,
miR-143, miR-101, miR-30c and miR-26a, have been shown in previous studies to regulate
insulin signalling and lipid metabolism and to be involved in diabetes [43–46], and thus they
may play important roles regulating changes in maternal metabolism occurring early during
pregnancy. In addition, miR-26a and let-7f have been shown to regulate macrophage- and T-
cell-mediated immunity [47–50] which would be consistent with a role in establishing mater-
nal immuno-tolerance, a key function during early pregnancy. Finally, miR-101, miR-205 and
miR-26a are known regulators of angiogenesis [51–54], a key process during development of
foeto-placental and maternal tissues during pregnancy.
Table 2. Most abundant miRNAs (RPMM) in bovine plasma on Days 0 and 60 of pregnancy (n = 11 heif-
ers) identified by sequencing.
miRNA Day 0 Day 60 Mean
bta-miR-486 163,304 187,148 175,226
bta-miR-22-3p 115,215 86,953 101,084
bta-miR-192 55,994 45,163 50,578
bta-miR-27b 50,069 39,846 44,957
bta-miR-143 16,617 67,181 41,899
bta-miR-10b 49,529 30,810 40,169
bta-miR-142-5p 31,254 40,063 35,659
bta-miR-191 32,881 33,804 33,343
bta-miR-423-5p 34,453 23,760 29,106
bta-miR-451 19,021 27,249 23,135
bta-miR-21-5p 21,387 24,164 22,775
bta-miR-101 17,776 25,853 21,814
bta-miR-92a 23,371 19,306 21,339
bta-miR-103 27,287 13,565 20,426
bta-miR-30d 17,498 18,882 18,190
https://doi.org/10.1371/journal.pone.0174892.t002
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Tissue-wide expression of plasma miRNAs associated with pregnancy
Next, to investigate the origin of these miRNAs, and at the same time gain further insight on their
potential roles during early pregnancy, we profiled the expression of all 7 miRNAs across 14 dif-
ferent bovine tissues, including blood cells. A total of 4 outliers were identified and removed from
each of let-7f, let-7c, miR-101 and miR-143 datasets. Six miRNAs (let-7c, let-7f, miR-101, miR-
143, miR-30c and miR-26a) were expressed in many different body tissues including the uterus
and the placenta, with no particular tissue being clearly enriched for any particular miRNA (Fig
3), overall consistent with data from human tissues [55, 56]. Notably, relative expression levels for
most miRNAs were lowest in both early (Day 70) and term placenta, indicating the developing
conceptus may not be a significant source of these miRNAs in plasma. In addition, expression
profiles suggested that, for all miRNAs except miR-143 and miR-205, blood cells are a significant
source of plasma levels, consistent with roles in immuno-regulation as suggested above. Interest-
ingly, mean levels of miR-205 were more than 8,000-fold higher in skin than in any other tissue
(Fig 3). In mammals, miR-205 was reportedly expressed in a range of tissues including the thy-
mus, mammary gland, early embryo, digestive tissue and skin [57–59, 55], however, different
studies highlighted the importance of miR-205 in regulating keratinocyte function [60, 61], which
is consistent with our results. Whether skin is indeed a significant contributor to circulating levels
of miR-205 should be explored in future studies.
A caveat associated with our tissue profiling approach is that all tissues analysed (other
than placenta) were collected from non-pregnant animals, which would not account for
changes in tissue miRNA expression that may only occur during pregnancy. However, since
our goal was to determine whether any of the miRNAs analysed (Fig 3) was specifically
expressed or highly enriched in a particular tissue, which we can reasonably assume will not
depend on pregnancy status, then the use of tissues from non-pregnant heifers for profiling
those miRNAs was justified.
Table 3. The 20 most stable miRNAs in bovine plasma from Days 0 and 60 of pregnancy identified using sequencing (n = 22 samples).
miRNA RPMM Coefficient of variation NormFinder stability value
bta-miR-128 2,687 15% 0.07
bta-miR-151-3p 6,732 16% 0.12
bta-miR-425-5p 1,724 17% 0.07
bta-miR-1307 266 20% 0.08
bta-miR-181b 1,295 21% 0.06
bta-miR-148a 15,092 21% 0.09
bta-miR-130b 1,085 21% 0.12
bta-miR-148b 351 21% 0.13
bta-miR-181a 13,983 22% 0.11
bta-miR-1842 113 23% 0.11
bta-miR-6119-3p 40 23% 0.12
bta-miR-92a 21,339 24% 0.13
bta-miR-30a-5p 6,808 26% 0.12
bta-miR-27b 44,957 27% 0.13
bta-miR-29c 733 27% 0.12
bta-miR-151-5p 1,667 27% 0.13
bta-miR-326 174 30% 0.13
bta-miR-744 318 31% 0.14
bta-miR-194 442 33% 0.13
bta-miR-224 86 37% 0.14
https://doi.org/10.1371/journal.pone.0174892.t003
miRNAs and early pregnancy
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Profiling of circulating miRNAs throughout early pregnancy
Finally, we sought to obtain further insight on these pregnancy-associated miRNAs by deter-
mining their temporal changes in circulation throughout early pregnancy. We hypothesised
that some of the miRNAs identified on Day 60 may actually begin increasing at earlier stages
of pregnancy (at or before Day 16), which could provide useful biomarkers of early pregnancy,
possibly in the form of a miRNA panel. Accordingly, we profiled all 7 miRNAs by RT-qPCR
on sequential plasma samples collected on Days 0, 8, 16 and 60 of pregnancy. We identified
and removed one outlier value for each of miR-101, miR-26a and let-7f on Day 8, and miR-
19a on Day 0. Analyses of the remaining data showed a significant effect of Day of pregnancy
(P< 0.05) for all 7 miRNAs (Fig 4). Moreover, mean levels of many miRNAs did not change
significantly until Day 60 (P < 0.05), with some miRNAs increasing gradually (non-signifi-
cantly) throughout early pregnancy, e.g. miR-30c. Remarkably, however, mean levels of miR-
26a were distinctly increased as early as Day 8 (3.1-fold; P = 0.046), resulting from a net
increase in miR-26a levels (ranging from 1.3- to 11.7-fold) in 8 of 10 animals between Days 0
and 8. In addition, levels of miR-101 tended to increase (2.3-fold, P = 0.069) on Day 16 relative
to Day 8 with no further elevation in mean levels of that miRNA up to Day 60 (Fig 4). Changes
in miRNA levels in circulation this early during pregnancy (i.e., Day 8) have not been reported
before and suggest a novel role for miR-26a, possibly through its immunomodulatory effects
[48, 49], very early during the establishment of pregnancy, a proposition that clearly deserves
further investigation. Although miR-26 has also been shown to play different roles presumably
unrelated to pregnancy [62–64], the robust (3-fold) increase in plasma miR-26 levels between
Table 4. Top differentially expressed miRNAs in plasma between Day 0 and 60 of pregnancy (n = 11
heifers).
miRNA Day 0* Day 60* Fold-change FDR
bta-let-7c 273 932 4.53 0.000
bta-miR-143 16617 67181 4.11 0.000
bta-miR-16a 1965 4212 2.68 0.048
bta-miR-155 250 477 2.32 0.000
bta-miR-19a 298 569 2.28 0.001
bta-miR-19b 1036 1913 2.13 0.003
bta-let-7f 4265 6502 2.12 0.012
bta-miR-32 387 792 2.01 0.002
bta-miR-374b 71 112 2.00 0.007
bta-miR-26a 9042 13806 1.95 0.006
bta-miR-26b 2971 4506 1.94 0.011
bta-miR-324 41 18 0.51 0.001
bta-miR-665 103 45 0.51 0.000
bta-miR-410 267 124 0.50 0.000
bta-miR-328 143 54 0.49 0.000
bta-miR-23a 7123 2795 0.49 0.000
bta-miR-99b 1142 414 0.49 0.002
bta-miR-424-3p 32 11 0.47 0.000
bta-miR-205 1072 344 0.46 0.000
hsa-miR-4532 945 229 0.42 0.000
*Values shown for Days 0 and 60 are mean RPMMs. Note that miR-4532 is a novel human homologue not
annotated in cow in miRBase 21.
https://doi.org/10.1371/journal.pone.0174892.t004
miRNAs and early pregnancy
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Days 8 and 0 of pregnancy suggest that miR-26a could be potentially used as a diagnostic bio-
marker as early as the first week of pregnancy, which could significantly facilitate reproductive
management of modern dairy herds. Lastly, because changes in miR-26a and miR-205 showed
opposite trends during early pregnancy we calculated the ratio between these 2 miRNAs to
determine whether this could provide an improved diagnostic biomarker; we found the miR-
26a / 205 ratio to increase 7.5-fold (P< 0.001) between Days 0 and 8 of pregnancy, providing
an even more robust, potential molecular indicator of very early pregnancy in cattle (Fig 4).
Conclusions
Our novel results using small RNA sequencing and RT-qPCR profiling show wide changes in
circulating miRNA profiles occurring by Day 60 of pregnancy in cattle, in contrast with the
Table 5. Genomic clusters represented by miRNAs differentially expressed in plasma between Days 0 and 60 of pregnancy (n = 11 heifers).
Cluster* Genomic location No. of miRNAs in cluster Differentially expressed miRNAs between Days 0 and 60 of pregnancy
miR-379~656 chr21:67561869–67604767 47 mir-380, mir-154c, mir-381, mir-369, mir-410
miR-424~450b chrX:18185439–18178985 7 mir-424, mir-450a-2, mir-450a-1, mir-450b
miR-493~136 chr21:67416605–67431509 7 mir-665, mir-136
miR-17~92 chr12:66226554–66227332 6 mir-17, mir-18a, mir-19a, mir-20a, mir-19b
let-7a-3~3596 chr5:117119385–117120270 4 let-7a-3, let-7b
let-7a-1~7d chr8:86884872–86887517 3 let-7a-1, let-7f-1
miR-106b~25 chr25:36892046–36892532 3 mir-106b, mir-93
miR-199a~214 chr16:40491602–40485916 3 mir-199a-1, mir-214
miR-23a~24 chr7:12981970–12981713 3 mir-23a, mir-27a
miR-452~3431 chrX:34665624–34662756 3 mir-452, mir-224, mir-3431
miR-99b~125b chr18:58014868–58015620 3 mir-99b, mir-125a
miR-100~let-7a-2 chr15:33353395–33347640 2 mir-100, let-7a-2
let-7-2~miR-98 chrX:96383532–96382746 2 let-7f-2, mir-98
*Only clusters for which at least 2 miRNAs were differentially expressed are shown
https://doi.org/10.1371/journal.pone.0174892.t005
Table 6. Differences in expression of plasma miRNAs between Days 0 and Day 60 of pregnancy (n = 11 heifers) obtained by sequencing and RT-
qPCR.
Next-generation sequencing RT-qPCR
miRNA Fold-change P value FDR Fold-change P value
bta-let-7c 4.53 0.000 0.000 5.30 0.015
bta-miR-143 4.11 0.000 0.000 6.11 0.015
bta-miR-155 2.32 0.000 0.000 4.60 0.053
bta-miR-19b 2.13 0.000 0.003 2.63 0.929
bta-let-7f 2.12 0.003 0.012 3.25 0.011
bta-miR-26a 1.95 0.001 0.006 6.22 0.009
bta-miR-26b 1.94 0.002 0.011 3.38 0.054
bta-miR-101 1.76 0.003 0.014 2.12 0.016
bta-miR-30c 1.67 0.032 0.075 5.50 0.006
bta-miR-23a 0.49 0.000 0.000 2.00 0.312
bta-miR-99b 0.49 0.000 0.002 2.20 0.687
bta-miR-152 0.46 0.031 0.073 2.21 0.869
bta-miR-205 0.46 0.000 0.000 0.67 0.012
hsa-miR-4532 0.42 0.000 0.000 0.77 0.161
https://doi.org/10.1371/journal.pone.0174892.t006
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much smaller differences previously reported from high-throughput analysis of small RNAs
earlier during pregnancy (Days 16 and 24) [23]. Specifically, we identify a subset of miRNAs
(let-7f, let-7c, miR-30c, miR-101, miR-26a, miR-205 and miR-143), the levels of which increase
distinctly in circulation (up to 6-fold) in Day 60 pregnant relative to non-pregnant (Day 0)
cows, and which provide novel molecular candidates involved in the establishment of preg-
nancy in cattle. Significantly, an increase in plasma levels of miR-26a was identified as early as
Day 8, much earlier than previously reported for any miRNA during pregnancy in any species,
suggesting one of the biological role of this miRNA may be in the very initial stages of preg-
nancy, providing a potential unique diagnostic biomarker of early pregnancy. Overall, the sub-
set of miRNAs identified in our study provide the basis to elucidate specific roles of miRNAs
during early pregnancy and for more comprehensive biomarker identification studies in the
future.
Fig 2. RT-qPCR validation of selected sequencing results. (A) Fold-changes in plasma miRNA levels (mean ± SEM) identified during pregnancy using
sequencing and RT-qPCR. (B) Relative expression (mean ± SEM, normalised to the mean expression of cel-miR-39-3p and miR-128) of 7 miRNAs on Days
0 and 60 of pregnancy obtained by RT-qPCR.
https://doi.org/10.1371/journal.pone.0174892.g002
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Fig 3. Expression of pregnancy-associated miRNAs in different tissues. Relative expression
(mean ± SEM, normalised to RNU6-2 expression) of pregnancy-associated miRNAs in 14 tissues from
healthy cows (n = 3 animals per tissue). Placenta: Placenta from Day 70 of pregnancy; Placenta (T): Term
placenta.
https://doi.org/10.1371/journal.pone.0174892.g003
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Fig 4. MiRNA profiles throughout early pregnancy determined by RT-qPCR. Relative expression
(mean ± SEM, normalised to the mean expression of cel-miR-39-3p and miR-128) of selected miRNAs in
miRNAs and early pregnancy
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